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Socioeconomic adversity—an important barrier to
healthy aging
Urgent action required to address socioeconomic inequalities in aging populations
Rachel Cooper senior lecturer
MRC Unit for Lifelong Health and Ageing at UCL, London WC1B 5JU, UK
As the global population ages there is concern that
improvements in disability-free life expectancy might not have
kept pace with the improvements in life expectancy that have
driven this major demographic trend over the past century. This
has important implications for individuals, families, and society;
not least because it might prevent realisation of the potential
opportunities of an aging population.1 Identifying the most
effective targets for intervention to ensure that people live not
only longer lives but also healthier, independent lives for longer
is therefore an international research priority.2
It is within this context that, in a linked article (doi:10.1136/
bmj.k1046), Stringhini and colleagues have assessed the
associations of low socioeconomic status and six other
non-communicable disease risk factors with walking speed in
later life. The authors selected these six other factors as they
had been identified by the World Health Organization as targets
for reducing premature mortality from chronic diseases by 25%
by 2025.4 Walking speed—a quick, easy, and commonly used
measure of physical capability—has two important strengths
as an outcome. Firstly, it can be used to detect existing
limitations in mobility5; a key threat to independent living.
Secondly, slower walking speed is consistently associated with
poorer health prospects, including lower survival rates and
higher rates of incident disability in older community dwelling
populations.6-8
Previous research cited by Stringhini and colleagues has shown
that lower socioeconomic status is associated with slower
walking speed in older populations and that these associations
extend back across life to childhood. By pooling results from
37 studies and 109 107 adults aged 45-90 years from 24
countries, these comprehensive new analyses are able to compare
the association of low socioeconomic status (usually based on
last known occupation) and walking speed with associations
with the six other WHO risk factors (obesity, smoking, high
alcohol intake, physical inactivity, hypertension, and diabetes).
Using walking speed to estimate the number of years of physical
functioning lost in association with each risk factor, the authors
show that low socioeconomic status is at least as important as
each of the six other factors. For example, in minimally adjusted
models, estimated years of functioning lost by age 60 years
among women were 4.6 (95% confidence interval 3.6 to 6.2)
for low socioeconomic status, 7.5 (6.1 to 9.5) for obesity, 0.7
(0.1 to 1.5) for smoking, 0.1 (−1.2 to 0.9) for high alcohol intake,
5.4 (4.3 to 7.3) for physical inactivity, 3.0 (2.3 to 4.0) for
hypertension, and 6.3 (4.9 to 8.4) for diabetes. These estimates
varied markedly by sex and country; men and participants from
high income countries lost more estimated years of functioning
in relation to low socioeconomic status than women and those
from low and middle income countries, respectively. However,
the same general trend was found in all analyses.
Caution is required in interpreting these specific estimates: there
is considerable heterogeneity within and between studies, and
the analyses are cross sectional so observed differences in
walking speed by age may also be attributable to cohort and
period effects. Nevertheless, the main message of this paper is
clear: socioeconomic adversity is an important target in global
efforts to extend disability-free life expectancy. Furthermore,
as socioeconomic status is more distal than the six other
non-communicable disease risk factors studied, and these and
other risk factors are socioeconomically patterned, there might
be greater and more far reaching benefit in targeting
socioeconomic adversity.
Another recent paper from the same research consortium
provided compelling evidence of the need to target low
socioeconomic status alongside other risk factors to reduce
premature mortality.9 Taken together, these findings highlight
the importance of socioeconomic adversity as a barrier to
different key aspects of healthy aging. In comparing the findings
of their two sets of analyses,3 9 the authors estimate that low
socioeconomic status is associated with more years of physical
functioning lost than years of life lost.
Although this is not surprising—previous research has
documented wider socioeconomic inequalities in disability-free
life expectancy than in overall life expectancy,10 it has important
implications. The new findings suggest that people who have
experienced socioeconomic adversity are not only more likely
to live shorter lives but also to live more of their shorter lives
with disability. Global increases in socioeconomic inequality11
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are a cause for concern, and Stringhini and colleagues provide
further evidence in support of renewed calls for action10 12 on
inequality as a matter of urgency to improve the health and
wellbeing of the aging global population.
With thanks to Diana Kuh for her helpful comments on an earlier draft of this
editorial.
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